Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways

Environmental Health Perspectives

Volumn 112, Issue 15, 2004, Pages 1481-1487

  Bulayeva, Nataliya N ^a   Watson, Cheryl S ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Environmental estrogens; ERKs; Estradiol; Phytoestrogens; Prolactinoma cell line; Rapid estrogen effects

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4 NONYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; CALCIUM ION; DIELDRIN; ENDOSULFAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN DERIVATIVE; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ORGANOCHLORINE PESTICIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOESTROGEN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; CELL STRAIN; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCRINE DISEASE; ESTROGEN ACTIVITY; GENE ACTIVATION; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; MAP KINASE KINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 3; PESTICIDES; PHOSPHORYLATION; PITUITARY NEOPLASMS; PROLACTINOMA; RATS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; XENOBIOTICS;

ANIMALIA;

EID: 8744306001     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7175     Document Type: Article

References (59)

1. Adeoya-Osiguwa SA, Markoulaki S, Pocock V, Milligan SR, Fraser LR. 2003. 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function. Hum Reprod 18:100-107.
2. Aronica SM, Kraus WL, Katzenellenbogen BS. 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521.
3. Belcheva MM, Coscia CJ. 2002. Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11:34-44.
4. Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM. 2001. Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology 158:141-153.
5. Brucker-Davis F, Thayer K, Colborn T. 2001. Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing. Environ Health Perspect 109(suppl 1):21-26.
6. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
7. Bulayeva NN, Gametchu B, Watson CS. 2004. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 69:181-192.
8. 3/B6 pituitary tumor cells using a quantitative plate immunoassay. Steroids 66:727-736.
9. Cappelletti V, Saturno G, Miodini P, Korner W, Daidone MG. 2003. Selective modulation of ER-beta by estradiol and xenoestrogens in human breast cancer cell lines. Cell Mol Life Sci 60:567-576.
10. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, et al. 2000. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87:E44-E52.
11. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn RE, Shaul PW. 1999. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406.
12. Cossette LJ, Gaumond I, Martinoli MG. 2002. Combined effect of xenoestrogens and growth factors in two estrogen-responsive cell lines. Endocrine 18:303-308.
13. i in female rat distal colon. Mol Cell Endocrinol 199:87-103.
14. Elsby R, Maggs JL, Ashby J, Paton D, Sumpter JP, Park BK. 2001. Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. J Pharmacol Exp Ther 296:329-337.
15. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S, et al. 1999. New insights into the control of MAP kinase pathways. Exp Cell Res 253:255-270.
16. Filardo EJ, Quinn JA, Bland KI, Frackelton AR. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649-1660.
17. Granek V, Rishpon J. 2002. Detecting endocrine-disrupting compounds by fast impedance measurements. Environ Sci Technol 36:1574-1578.
18. Gutendorf B, Westendorf J. 2001. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166:79-89.
19. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, et al. 2003. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278:2118-2123.
20. Hodges LC, Bergerson JS, Hunter DS, Walker CL. 2000. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro. Toxicol Sci 54:355-364.
21. Inoue A, Hayashi S, Aoyagi K, Nishigaki M, Sasaki H, Kiyama R. 2002. A reporter gene assay for evaluation of tissue-specific responses to estrogens based on the differential use of promoters A to F of the human estrogen receptor alpha gene. J Pharmacol Toxicol Methods 47:129-135.
22. Kelly MJ, Lagrange AH, Wagner EJ, Ronnekleiv OK. 1999. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64:64-75.
23. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. 1993. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279-2286.
24. Lee HS, Miyauchi K, Nagata Y, Fukuda R, Sasagawa S, Endoh H, et al. 2002. Employment of the human estrogen receptor beta ligand-binding domain and co-activator SRC1 nuclear receptor-binding domain for the construction of a yeast two-hybrid detection system for endocrine disrupters. J Biochem (Tokyo) 131:399-405.
25. Levin ER. 1999. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 10:374-377.
26. Long XH, Steinmetz R, Ben Jonathan N, Caperell-Grant A, Young PCM, Nephew KP, et al. 2000. Strain differences in vaginal responses to the xenoestrogen bisphenol A. Environ Health Perspect 108:243-247.
27. Lowes VL, Ip NY, Wong YH. 2002. Integration of signals from receptor tyrosine kinases and g protein-coupled receptors. Neurosignals 11:5-19.
28. MacDonald MJ, Al Masri H, Jumelle-Laclau M, Cruz MO. 1997. Oscillations in activities of enzymes in pancreatic islet subcellular fractions induced by physiological concentrations of effectors. Diabetes 46:1996-2001.
29. Massaad C, Barouki R. 1999. An assay for the detection of xenoestrogens based on a promoter containing overlapping EREs. Environ Health Perspect 107:563-566.
30. McLachlan JA. 1993. Functional toxicology: a new approach to detect biologically active xenobiotics. Environ Health Perspect 101:386-387.
31. Murray AW. 2004. Recycling the cell cycle: cyclins revisited. Cell 116:221-234.
32. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B. 2000. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA 97:11603-11608.
33. Nadal A, Rovira JM, Laribi O, Leonquinto T, Andreu E, Ripoll C, et al. 1998. Rapid insulinotropic effect of 17-β-estradiol via a plasma membrane receptor. FASEB J 12:1341-1348.
34. 3/B6/F10 rat pituitary cells by enzyme-linked immunocytochemistry. Endocrinology 140:3805-3814.
35. 3/B6 cells are associated with rapid estrogen-induced release of prolactin. Endocrine 2:813-822.
36. Pasapera Limon AM, Herrera-Munoz J, Gutierrez-Sagal R, Ulloa-Aguirre A. 2003. The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene. Mol Cell Endocrinol 200:199-202.
37. Prevot V, Croix D, Rialas CM, Poulain P, Fricchione GL, Stefano GB, et al. 1999. Estradiol coupling to endothelial nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor. Endocrinology 140:652-659.
38. Rajapakse N, Silva E, Kortenkamp A. 2002. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 110:917-921.
39. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER. 2002. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115.
40. Razandi M, Pedram A, Park ST, Levin ER. 2003. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278:2701-2712.
41. Recchia AG, Vivacqua A, Gabriele S, Carpino A, Fasanella G, Rago V, et al. 2004. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha. Food Addit Contam 21:134-144.
42. Rosselli M, Reinhart K, Imthurn B, Keller PJ, Dubey RK. 2000. Cellular and biochemical mechanisms by which environmental oestrogens influence reproductive function. Hum Reprod Update 6:332-350.
43. Rousseau J, Cossette L, Grenier S, Martinoli MG. 2002. Modulation of prolactin expression by xenoestrogens. Gen Comp Endocrinol 126:175-182.
44. Ruehlmann DO, Steinert JR, Valverde MA, Jacob R, Mann GE. 1998. Environmental estrogenic pollutants induce acute vascular relaxation by inhibiting L-type Ca2+ channels in smooth muscle cells. FASEB J 12:613-619.
45. Sato K, Matsuki N, Ohno Y, Nakazawa K. 2003. Estrogens inhibit I-glutamate uptake activity of astrocytes via membrane estrogen receptor alpha. J Neurochem 86:1498-1505.
46. Sonnenschein C, Soto AM, Fernandez MF, Olea N, Olea-Serrano MF, Ruiz-Lopez MD. 1995. Development of a marker of estrogenic exposure in human serum. Clin Chem 41:1888-1895.
47. Soto AM, Chung KL, Sonnenschein C. 1994. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 102:380-383.
48. Suzuki T, Ide K, Ishida M, Shapiro S. 2001. Classification of environmental estrogens by physicochemical properties using principal component analysis and hierarchical cluster analysis. J Chem Inf Comput Sci 41:718-726.
49. Tsai KS, Yang RS, Liu SH. 2004. Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway. Chem Res Toxicol 17:679-684.
50. Turner KO, Syvanen M, Meizel S. 1997. The human acrosome reaction is highly sensitive to inhibition by cyclodiene insecticides. J Androl 18:571-575.
51. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, et al. 2001. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276:48269-48275.
52. van Lipzig MM, ter Look AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, et al. 2004. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. J Med Chem 47:1018-1030.
53. Watson CS, Campbell CH, Gametchu B. 1999a. Membrane estrogen receptors on rat pituitary tumor cells: immunoidentification and responses to estradiol and xenoestrogens. Exp Physiol 84:1013-1022.
54. 3/B6 pituitiary tumor cells via a plasma membrane version of estrogen receptor-γ. Steroids 64:5-13.
55. Watson CS, Pappas TC, Gametchu B. 1995. The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ Health Perspect 103(suppl 7):41-50.
56. Willard SP, Frawley LS. 1998. Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells. Endocrine 8:117-121.
57. Witorsch RJ. 2002. Endocrine disruptors: can biological effects and environmental risks be predicted? Regul Toxicol Pharmacol 36:118-130.
58. Wober J, Weisswange I, Vollmer G. 2002. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens. J Steroid Biochem Mol Biol 83:227-233.
59. Yu SJ, Keenan SM, Tong W, Welsh WJ. 2002. Influence of the structural diversity of data sets on the statistical quality of three-dimensional quantitative structure-activity relationship (3D-QSAR) models: predicting the estrogenic activity of xenoestrogens. Chem Res Toxicol 15:1229-1234.